Nasdaq files Form 25 to delist Longevity Health Holdings securities

Rhea-AI Filing Summary

Longevity Health Holdings, Inc. has had its common stock and warrants removed from listing and/or registration on the Nasdaq Stock Market LLC, as reflected in a Form 25 notification filed by the exchange. The filing states that Nasdaq has complied with its rules to strike these classes of securities from listing and withdraw their registration under Section 12(b) of the Securities Exchange Act of 1934.

This action means the company’s securities will no longer trade on Nasdaq, which can affect trading visibility and access for many investors. The notification is signed on behalf of Nasdaq by a hearings advisor, confirming the exchange’s belief that it meets all requirements for filing Form 25.

Positive

• None.

Negative

• Common stock and warrants removed from Nasdaq listing, which can reduce liquidity, visibility, and ease of trading for Longevity Health Holdings, Inc. securities.

Insights

Equity Markets & Listing Standards Analyst

Nasdaq is removing Longevity Health’s stock and warrants from listing.

The Form 25 shows that Longevity Health Holdings, Inc. common stock and warrants are being removed from listing and/or registration on Nasdaq Stock Market LLC under Section 12(b) of the Exchange Act. The exchange certifies that it has complied with its own rules and the provisions of 17 CFR 240.12d2-2(b) to strike these securities.

When a security is delisted from a major exchange, trading often shifts to less visible venues, which can reduce liquidity and widen bid-ask spreads for investors. The filing does not describe the specific reasons or any follow-on trading arrangements, so the main confirmed impact is the loss of a Nasdaq listing for the company’s common stock and warrants.

Investors who hold these securities typically monitor subsequent company disclosures to see where and how the securities may trade after removal from Nasdaq, and whether any changes to reporting obligations or capital markets strategy are announced in later filings.

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

333-253876

Issuer:	Longevity Health Holdings, Inc.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	2403 Sidney Street, Suite 300
	Pittsburgh	PENNSYLVANIA	15203
Telephone number:					(646) 494-3296

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Stock, Warrants

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-11-21	By	Aravind Menon		Hearings Advisor
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Nasdaq Form 25 filing disclose about Longevity Health Holdings (XAGE)?

The filing disclosed that Longevity Health Holdings, Inc. common stock and warrants are being removed from listing and/or registration on the Nasdaq Stock Market LLC under Section 12(b) of the Exchange Act.

Which Longevity Health Holdings (XAGE) securities are affected by this Form 25?

The Form 25 covers common stock and warrants of Longevity Health Holdings, Inc., which are being struck from listing and/or registration on Nasdaq.

Who filed the Form 25 for Longevity Health Holdings (XAGE) and under what authority?

The Form 25 was filed by Nasdaq Stock Market LLC, which certifies that it has complied with its rules and with 17 CFR 240.12d2-2(b) to strike the class of securities from listing and withdraw registration under Section 12(b).

What does removal from Nasdaq listing mean for Longevity Health Holdings (XAGE) investors?

Removal from Nasdaq generally means the company’s securities no longer trade on that exchange, which can affect trading liquidity and visibility, though the filing does not state where the securities might trade afterward.

Does the Longevity Health Holdings (XAGE) Form 25 explain why Nasdaq is delisting the securities?

The excerpt states that Nasdaq has complied with its rules and the requirements of 17 CFR 240.12d2-2, but it does not describe specific reasons for the removal of the common stock and warrants.

Who signed the Longevity Health Holdings (XAGE) Form 25 on behalf of Nasdaq?

The notification is signed on behalf of Nasdaq Stock Market LLC by Aravind Menon, identified as a Hearings Advisor, certifying Nasdaq’s reasonable grounds for filing the Form 25.